Infochem
- Company typePrivate
- Founded1989
- HeadquartersMunich, Germany
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Infochem firmographics
Firmographics- Name
- Infochem
- Website
- https://infochem.de
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Infochem industry classification
Industry- Product category
- AI Drug Discovery and Process Chemistry Software
- NAICS
- Computer Systems Design and Related Services (54151)
- akta.pro primary industry
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)
- akta.pro secondary industries
- Small-Molecule API Process Development & Route Scouting (HLAGAHAA), Chiral / Asymmetric Synthesis & Complex Chemistry Services (HLAGAHAE)
Keywords
Where Infochem is headquartered
LocationHeadquarters
- HQ city
- Munich
- HQ country
- Germany
- HQ region
- Europe
Markets served
Infochem business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- AI Route Discovery Services: B2B service model providing AI-driven synthetic route discovery for pharmaceutical manufacturers. Revenue generated through project-based engagements where ChemAI discovers, validates, and delivers optimized manufacturing routes for client molecules. Model includes discovery, in-silico validation, and lab confirmation phases.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Infochem product offering
Product offeringCore offering
Infochem provides AI-driven synthetic route discovery and chemistry intelligence for pharmaceutical manufacturers. Its flagship platform ChemAI combines a proprietary AI core called SmartChemistry© with expert chemistry support to evaluate feasibility, optimize routes, and accelerate manufacturing decisions across generic, specialty, originator, and global health programs.
Product overview
Infochem offers ChemAI as a unified AI-powered platform for synthetic route discovery in the pharmaceutical and chemical manufacturing industries. The platform is anchored by SmartChemistry, a proprietary AI technology that generates and ranks millions of potential synthetic pathways for target molecules. The workflow progresses through four stages: target and constraints definition, AI route discovery, in-silico costing and greenness scoring, and IP/lab validation. The platform serves generic manufacturers, originator companies, and global health programs seeking cost-optimized, patent-defensible synthesis routes.
Differentiator
Problem solved
Functional benefit
Products and services
- ChemAI AI-powered retrosynthetic route planning and process optimization platform built for pharmaceutical manufacturers, enabling faster evaluation of synthetic routes and chemistry feasibility decisions.
Quantifiable outcome
- End-to-end yield improvement from 17% to 42% for Phase III antimalarial candidate
- +2 more outcomes
Companies that use Infochem
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles1 record
Infochem technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
Infochem partnerships and signals
Strategic signalScale indicators4 records
Recent moves3 records
Expansion highlights4 records
Infochem competitors and assessment
Company assessmentDirect peers
- Schrödinger: Provider of computational chemistry and molecular simulation platforms used in drug discovery and materials science. Comparable to Infochem because both build physics- and AI-driven software that predicts molecular properties and synthesis behaviour for pharma R&D.
- Synthia (formerly Chematica, Merck KGaA): Retrosynthesis planning software using a curated reaction network and AI/algorithmic search to propose synthesis routes. Direct overlap with Infochem's route-discovery and process-chemistry use cases for pharma and fine chemicals.
- PostEra: AI-driven medicinal chemistry platform offering synthesis planning alongside drug discovery (e.g., COVID Moonshot). Comparable as an AI chemistry company targeting pharma with predictive synthesis and route optimisation workflows.
- IBM RXN: IBM Research's AI retrosynthesis platform that maps and ranks synthetic routes for target molecules. Directly comparable to SmartChemistry© as a machine-learning-driven forward-synthesis / retrosynthesis tool for chemists.
Emerging players
- Insilico Medicine: AI-driven drug discovery company with a Chemistry42 generative chemistry platform for molecule design and synthesis prediction. Overlaps with Infochem on AI-enabled chemistry for pharma, though Insilico focuses end-to-end on drug discovery.
- Citrine Informatics: AI platform for materials and chemicals R&D that uses data-driven models to optimise formulations and processes. Comparable because it applies AI to chemistry engineering workflows, though focused on materials rather than pharma route discovery.
Broad incumbents
- Dotmatics: Enterprise scientific informatics platform used across pharma R&D labs for chemistry, biology, and workflow data. Comparable as an adjacent software vendor serving chemistry and process R&D teams with digital tools.
- CAS (Chemical Abstracts Service): Operator of SciFinder and the CAS registry, providing curated chemistry information and predictive retrosynthesis capabilities. Comparable as an established cheminformatics incumbent with overlapping route-discovery and IP clearance use cases.
- Reaxys (Elsevier): Large chemistry database and reaction-search platform widely used in pharma process R&D. Overlaps with Infochem in synthesis-route planning and is a broader incumbent whose reactions database underpins many retrosynthesis tools.
- OpenEye Scientific (Cadence Molecular Sciences): Molecular modelling and cheminformatics software provider serving pharma and academic chemistry groups. Comparable as a scientific software vendor whose tools support computational chemistry workflows in drug discovery and development.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Infochem social profiles
Digital presenceInfochem financial estimates
Financial estimateRevenue estimate
Valuation estimate
Infochem leadership team
Management profileNumber of profiles
Infochem funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Infochem M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Infochem
What does Infochem do?
Infochem provides AI-driven synthetic route discovery and chemistry intelligence for pharmaceutical manufacturers. Its flagship platform ChemAI combines a proprietary AI core called SmartChemistry© with expert chemistry support to evaluate feasibility, optimize routes, and accelerate manufacturing decisions across generic, specialty, originator, and global health programs.
When was Infochem founded?
Infochem was founded in 1989. It employs 11 to 50 people.
Where is Infochem based?
Infochem is headquartered in Munich, Germany, in the Europe region.
How does Infochem make money?
One revenue line is on record: AI Route Discovery Services.
Who are Infochem's main competitors?
Direct peers on record are Schrödinger, Synthia (formerly Chematica, Merck KGaA), PostEra and IBM RXN. Emerging players are Insilico Medicine and Citrine Informatics. Broad incumbents are Dotmatics, CAS (Chemical Abstracts Service), Reaxys (Elsevier) and OpenEye Scientific (Cadence Molecular Sciences).
Does Infochem have an API?
No public API is recorded for Infochem.
What industry is Infochem in?
Infochem's product category is AI Drug Discovery and Process Chemistry Software. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAGAHAA, Small-Molecule API Process Development & Route Scouting. Its NAICS code is 54151.